FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Ciprofloxacin Hydrochloride, Dexamethasone Suspension/ Drops
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Novartis Pharmaceuticals Corporation (New 06/26/2023)

Company Contact Information:
888-669-6682

Presentation	Posting Date	Related Information
Ciprodex, Suspension/ Drops, 3 mg/1 mL; 1 mg/1 mL (NDC 0078-0799-75)	06/26/2023	Novartis Pharmaceuticals has made a business decision to permanently discontinue CIPRODEX (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension.Discontinuation of the product is not due to manufacturing, product quality, safety, or efficacy concerns. Product will be available until approximately September 2023. The authorized generic, NDC 0781-6186-67, will continue to be manufactured and available, distributed by Sandoz. Other generic equivalents are also available.